Machine learning for adverse event prediction in outpatient parenteral antimicrobial therapy: a scoping review

被引:1
|
作者
Challener, Douglas W. [1 ]
Fida, Madiha [1 ]
Martin, Peter [2 ]
Rivera, Christina G. [3 ]
Virk, Abinash [1 ]
Walker, Lorne W. [4 ,5 ]
机构
[1] Mayo Clin, Div Publ Hlth Infect Dis & Occupat Med, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN USA
[3] Mayo Clin, Dept Pharm, Rochester, MN USA
[4] Oregon Hlth & Sci Univ, Div Pediat Infect Dis, Portland, OR USA
[5] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA
关键词
ANTIBIOTIC-THERAPY; RISK-FACTORS; HEALTH-CARE; VANCOMYCIN; INFUSION; READMISSIONS; DAPTOMYCIN; MODEL; OPAT;
D O I
10.1093/jac/dkae340
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective This study aimed to conduct a scoping review of machine learning (ML) techniques in outpatient parenteral antimicrobial therapy (OPAT) for predicting adverse outcomes and to evaluate their validation, implementation and potential barriers to adoption.Materials and methods This scoping review included studies applying ML algorithms to adult OPAT patients, covering techniques from logistic regression to neural networks. Outcomes considered were medication intolerance, toxicity, catheter complications, hospital readmission and patient deterioration. A comprehensive search was conducted across databases including Cochrane Central, Cochrane Reviews, Embase, Ovid MEDLINE and Scopus, from 1 January 2000 to 1 January 2024.Results Thirty-two studies met the inclusion criteria, with the majority being single-centre experiences primarily from North America. Most studies focused on developing new ML models to predict outcomes such as hospital readmissions and medication-related complications. However, there was very little reporting on the performance characteristics of these models, such as specificity, sensitivity and C-statistics. There was a lack of multi-centre or cross-centre validation, limiting generalizability. Few studies advanced beyond traditional logistic regression models, and integration into clinical practice remains limited.Discussion ML shows promise for enhancing OPAT outcomes by predicting adverse events and enabling pre-emptive interventions. Despite this potential, significant gaps exist in development, validation and practical implementation. Barriers include the need for representative data sets and broadly applicable, validated models.Conclusion Future research should address these barriers to fully leverage ML's potential in optimizing OPAT care and patient safety. Models must deliver timely, accurate and actionable insights to improve adverse event prediction and prevention in OPAT settings.
引用
收藏
页码:3055 / 3062
页数:8
相关论文
共 50 条
  • [41] Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study
    Yan, Marie
    Elligsen, Marion
    Simor, Andrew E.
    Daneman, Nick
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2016, 2016
  • [42] A Bundle of the "Top 10" Outpatient Parenteral Antimicrobial Therapy Publications in 2023
    Childs-Kean, Lindsey M.
    Beieler, Alison M.
    Cortes-Penfield, Nicolas
    Keller, Sara C.
    Rivera, Christina G.
    Ryan, Keenan L.
    Yoke, Leah H.
    Mahoney, Monica, V
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (11):
  • [43] Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
    Kilinc, Fatma
    Setzer, Matthias
    Behmanesh, Bedjan
    Jussen, Daniel
    Gessler, Florian
    Keil, Fee
    Kempf, Volkhard A. J.
    Kessel, Johanna
    Czabanka, Marcus
    Prinz, Vincent
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [44] Outpatient parenteral antimicrobial therapy in Germany: a prospective cohort study protocol
    Scholten, Nadine
    Leisse, Charlotte
    Brandes, Vanessa
    Oberroehrmann, Charlotte
    Ihle, Peter
    Peter, Sophie
    Hagemeier, Anna
    Hellmich, Martin
    Lindemann, Christoph H.
    Samel, Christina
    Pfaff, Holger
    Lehmann, Clara
    BMJ OPEN, 2022, 12 (11):
  • [45] Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
    Johnson, Tanner M.
    Webster, Leah Whitman C.
    Mehta, Meera
    Johnson, Jessica E.
    Cortes-Penfield, Nicolas
    Rivera, Christina G.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2023, 10
  • [46] Patterns of outpatient ceftriaxone use in a Japanese general hospital: an increased need for development of outpatient parenteral antimicrobial therapy programs
    Hase, Ryota
    Hosokawa, Naoto
    INFECTIOUS DISEASES, 2015, 47 (09) : 668 - 671
  • [47] Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors
    Robins, Alison
    Dishner, Emma
    McDaneld, Patrick
    Rowan, Meagan
    Bartek, Jalen
    Jiang, Ying
    Adachi, Javier
    Dailey Garnes, Natalie J. M.
    SUPPORTIVE CARE IN CANCER, 2022, 30 (02) : 1643 - 1654
  • [48] Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis-Model of Care
    Rajaratnam, Dylan
    Rajaratnam, Rohan
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [49] The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy
    Hodgson, Kate A.
    Huynh, Julie
    Ibrahim, Laila F.
    Sacks, Bronwyn
    Golshevsky, Daniel
    Layley, Michael
    Spagnolo, Mark
    Raymundo, Chin-Mae
    Bryant, Penelope A.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (10) : 886 - 893
  • [50] Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy
    Tice, AD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 : 83 - 86